551 related articles for article (PubMed ID: 17326013)
1. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands.
Krause K; Schnitger A; Fimmel S; Glass E; Zouboulis CC
Horm Metab Res; 2007 Feb; 39(2):166-70. PubMed ID: 17326013
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes.
Zouboulis CC; Seltmann H; Hiroi N; Chen W; Young M; Oeff M; Scherbaum WA; Orfanos CE; McCann SM; Bornstein SR
Proc Natl Acad Sci U S A; 2002 May; 99(10):7148-53. PubMed ID: 12011471
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris.
Ganceviciene R; Graziene V; Fimmel S; Zouboulis CC
Br J Dermatol; 2009 Feb; 160(2):345-52. PubMed ID: 19077080
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells.
Heldwein KA; Redick DL; Rittenberg MB; Claycomb WC; Stenzel-Poore MP
Endocrinology; 1996 Sep; 137(9):3631-9. PubMed ID: 8756527
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
6. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
Boorse GC; Denver RJ
Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
[TBL] [Abstract][Full Text] [Related]
7. Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype.
Graziani G; Tentori L; Muzi A; Vergati M; Tringali G; Pozzoli G; Navarra P
Mol Cell Endocrinol; 2007 Jan; 264(1-2):44-9. PubMed ID: 17097220
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CRH receptors in urocortin-induced hyperthermia.
Telegdy G; Adamik A
Peptides; 2008 Nov; 29(11):1937-42. PubMed ID: 18775757
[TBL] [Abstract][Full Text] [Related]
9. Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain.
Berger H; Heinrich N; Wietfeld D; Bienert M; Beyermann M
Br J Pharmacol; 2006 Dec; 149(7):942-7. PubMed ID: 17057757
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes.
Slominski AT; Roloff B; Zbytek B; Wei ET; Fechner K; Curry J; Wortsman J
In Vitro Cell Dev Biol Anim; 2000 Mar; 36(3):211-6. PubMed ID: 10777063
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing hormone and urocortin: redundant or distinctive functions?
Gysling K; Forray MI; Haeger P; Daza C; Rojas R
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):116-25. PubMed ID: 15572167
[TBL] [Abstract][Full Text] [Related]
12. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
Singh LK; Boucher W; Pang X; Letourneau R; Seretakis D; Green M; Theoharides TC
J Pharmacol Exp Ther; 1999 Mar; 288(3):1349-56. PubMed ID: 10027877
[TBL] [Abstract][Full Text] [Related]
13. Role of corticotropin-releasing hormone and receptor in the pathogenesis of psoriasis.
Zhou C; Yu X; Cai D; Liu C; Li C
Med Hypotheses; 2009 Oct; 73(4):513-5. PubMed ID: 19560286
[TBL] [Abstract][Full Text] [Related]
14. The type 2 corticotrophin-releasing hormone receptor mediates orexin A-induced luteinising hormone suppression in ovariectomised rats.
Iwasa T; Matsuzaki T; Kiyokawa M; Shimizu F; Minakuchi M; Kuwahara A; Maegawa M; Yasui T; Irahara M
J Neuroendocrinol; 2007 Sep; 19(9):732-8. PubMed ID: 17680889
[TBL] [Abstract][Full Text] [Related]
15. Characterization of [125I]sauvagine binding to CRH2 receptors: membrane homogenate and autoradiographic studies.
Rominger DH; Rominger CM; Fitzgerald LW; Grzanna R; Largent BL; Zaczek R
J Pharmacol Exp Ther; 1998 Jul; 286(1):459-68. PubMed ID: 9655891
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation.
Webster EL; Barrientos RM; Contoreggi C; Isaac MG; Ligier S; Gabry KE; Chrousos GP; McCarthy EF; Rice KC; Gold PW; Sternberg EM
J Rheumatol; 2002 Jun; 29(6):1252-61. PubMed ID: 12064844
[TBL] [Abstract][Full Text] [Related]
17. Activation of platelet-activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production.
Zhang Q; Seltmann H; Zouboulis CC; Travers JB
Exp Dermatol; 2006 Oct; 15(10):769-74. PubMed ID: 16984258
[TBL] [Abstract][Full Text] [Related]
18. Potential uses of corticotropin-releasing hormone antagonists.
Zoumakis E; Rice KC; Gold PW; Chrousos GP
Ann N Y Acad Sci; 2006 Nov; 1083():239-51. PubMed ID: 17148743
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
[TBL] [Abstract][Full Text] [Related]
20. Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors.
Suda T; Kageyama K; Sakihara S; Nigawara T
Peptides; 2004 Oct; 25(10):1689-701. PubMed ID: 15476936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
